Six months after approval, Paxlovid is rarely used. However, the only antiviral drug authorized in France has been proven to be effective. it reduces the risk of progression to severe Covid (hospitalization or death) by 87.8% when taken within five days of the first symptoms. It is recommended for people at risk of severe disease, those with co-morbidities or immunodeficiency, and for people over 60, according to Medicare, it is prescribed to only 20,000 patients. It’s a laughable figure when we know that in one day on July 22, there were 971 new cases among people over 60, according to Public Health France. This will not be a stock problem, this is enough to “meet current and future needs”, assures the Ministry of Health, which, however, refuses to reveal its exact level.
“This number remains insufficient compared to the United States, for example, where the Test & Treat strategy (diagnose and treat…
Source: Le Figaro
